New PET biomarker zeroes in on malignant breast tumors
Preclinical results of a study on a new PET biomarker called NVB-64 showed the agent can localize malignant breast tumors. The new biomarker has the ability to identify genetic changes at the cellular level and can also be modified to carry a therapeutic isotope. "The use of NVB64-PET scan in the future may minimize the need for unnecessary biopsy of benign tumors," the lead investigator said.
Reuters | 10/29
This story published in SNM SmartBrief on 10/30/2009
More from SmartBrief:
Researchers find new way to attach fluorine atoms to compounds
Wednesday, August 12, 2009
PET PROS (PET Professional References and Outreach Source)
Tuesday, July 28, 2009
Positron expects increased demand for cardiac PET imaging in 2010
Tuesday, September 29, 2009
Get stories like these delivered daily for FREE:
|
SNM SmartBrief
Designed specifically for nuclear medicine and molecular imaging professionals, SNM SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession. Learn more |
|